Cancer immunotherapy is a treatment that utilizes the host immune system to fight against
cancer. Inducing a cancer antigen-specific adaptive immune response is key in cancer …

This research evaluates the effects of laminarin on the maturation of dendritic cells and on
the in vivo activation of anti-cancer immunity. In vivo treatment of C56BL/6 mice with …

The stimulation of a specific antitumor immune response, involving the recruitment of T cells
and induction of T-cell effector functions, is an attractive possibility for cancer …

Described in several epithelial cancer cells, Tn-(GalNAcα1-O-Ser/Thr) and T-
(Galβ3GalNAcα1-O-Ser/Thr) antigens are examples of tumor-associated antigens …

Radiotherapy (RT) has been considered a local modality and outcomes have emphasized
local and regional control of tumors. Recent data suggests that RT may activate the immune …

Carcinoembryonic antigen (CEA) is a human glycoprotein involved in cellular adhesion and
expressed during human fetal development. Although expression of CEA largely ceases …

Background/Aims: Members of the melanoma antigen encoding gene family are expressed
in tumors of different histological types but not in normal tissue. For this reason, they are …

During the last decade, the aberrant expression of normal testicular proteins in
neoplastically transformed cells became common knowledge. Cancer-testis antigens (CTAs) …

NY-ESO-1, a commonly expressed tumor antigen of the cancer-testis family, is expressed by
a wide range of tumors but not found in normal adult somatic tissue, making it an ideal …

NY‐ESO‐1 is a cancer testis antigen expressed in various malignancies and testicular germ
cells. Because of its capacity to induce specific humoral and cellular immunity in patients …